Annual CFF
$3.73 M
-$1.40 M-27.25%
31 December 2023
Summary:
BioCardia annual cash flow from financing activities is currently $3.73 million, with the most recent change of -$1.40 million (-27.25%) on 31 December 2023. During the last 3 years, it has fallen by -$24.48 million (-86.79%). BCDA annual CFF is now -86.79% below its all-time high of $28.21 million, reached on 31 December 2020.BCDA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$6.12 M
+$4.33 M+242.59%
30 September 2024
Summary:
BioCardia quarterly cash flow from financing activities is currently $6.12 million, with the most recent change of +$4.33 million (+242.59%) on 30 September 2024. Over the past year, it has increased by +$6.18 million (+10655.17%). BCDA quarterly CFF is now -64.88% below its all-time high of $17.43 million, reached on 31 December 2020.BCDA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$10.40 M
+$6.18 M+146.31%
30 September 2024
Summary:
BioCardia TTM cash flow from financing activities is currently $10.40 million, with the most recent change of +$6.18 million (+146.31%) on 30 September 2024. Over the past year, it has increased by +$4.10 million (+65.09%). BCDA TTM CFF is now -65.57% below its all-time high of $30.22 million, reached on 31 March 2021.BCDA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCDA Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -27.3% | +10000.0% | +65.1% |
| 3 y3 years | -86.8% | +10000.0% | -46.3% |
| 5 y5 years | -2.0% | -38.1% | -24.0% |
BCDA Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -86.8% | +91.4% | at high | >+9999.0% | -46.3% | >+9999.0% |
| 5 y | 5 years | -86.8% | +91.4% | -64.9% | +9237.3% | -65.6% | >+9999.0% |
| alltime | all time | -86.8% | +317.3% | -64.9% | +438.5% | -65.6% | +652.3% |
BioCardia Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.12 M(+242.6%) | $10.40 M(+146.3%) |
| June 2024 | - | $1.79 M(+29.9%) | $4.22 M(-16.2%) |
| Mar 2024 | - | $1.38 M(+23.0%) | $5.04 M(+35.2%) |
| Dec 2023 | $3.73 M(-27.3%) | $1.12 M(-2029.3%) | $3.73 M(-40.9%) |
| Sept 2023 | - | -$58.00 K(-102.2%) | $6.30 M(-2.0%) |
| June 2023 | - | $2.60 M(+3964.1%) | $6.43 M(+24.0%) |
| Mar 2023 | - | $64.00 K(-98.3%) | $5.19 M(+1.2%) |
| Dec 2022 | $5.12 M(+163.1%) | $3.69 M(+4961.6%) | $5.12 M(+258.9%) |
| Sept 2022 | - | $73.00 K(-94.6%) | $1.43 M(+4.8%) |
| June 2022 | - | $1.35 M(>+9900.0%) | $1.36 M(-2448.3%) |
| Mar 2022 | - | $0.00(0.0%) | -$58.00 K(-103.0%) |
| Dec 2021 | $1.95 M(-93.1%) | $0.00(-100.0%) | $1.95 M(-90.0%) |
| Sept 2021 | - | $8000.00(-112.1%) | $19.38 M(+0.4%) |
| June 2021 | - | -$66.00 K(-103.3%) | $19.30 M(-36.1%) |
| Mar 2021 | - | $2.00 M(-88.5%) | $30.22 M(+7.1%) |
| Dec 2020 | $28.21 M(+187.3%) | $17.43 M(<-9900.0%) | $28.21 M(+163.4%) |
| Sept 2020 | - | -$67.00 K(-100.6%) | $10.71 M(-48.2%) |
| June 2020 | - | $10.85 M(>+9900.0%) | $20.66 M(+110.5%) |
| Mar 2020 | - | $0.00(-100.0%) | $9.82 M(0.0%) |
| Dec 2019 | $9.82 M(+158.1%) | -$67.00 K(-100.7%) | $9.82 M(-28.3%) |
| Sept 2019 | - | $9.88 M(>+9900.0%) | $13.68 M(+260.2%) |
| June 2019 | - | $0.00(0.0%) | $3.80 M(0.0%) |
| Mar 2019 | - | $0.00(-100.0%) | $3.80 M(-0.1%) |
| Dec 2018 | $3.80 M(+2541.7%) | $3.80 M(>+9900.0%) | $3.80 M(+2992.7%) |
| Sept 2018 | - | $0.00(0.0%) | $123.00 K(-3.1%) |
| June 2018 | - | $0.00(-100.0%) | $127.00 K(0.0%) |
| Mar 2018 | - | $5000.00(-95.8%) | $127.00 K(-11.8%) |
| Dec 2017 | $144.00 K(-96.7%) | $118.00 K(+2850.0%) | $144.00 K(+453.8%) |
| Sept 2017 | - | $4000.00(>+9900.0%) | $26.00 K(+18.2%) |
| June 2017 | - | $0.00(-100.0%) | $22.00 K(0.0%) |
| Mar 2017 | - | $22.00 K(>+9900.0%) | $22.00 K(-104.4%) |
| Dec 2016 | $4.40 M(-979.2%) | - | - |
| Dec 2011 | -$500.00 K(-200.0%) | $0.00(0.0%) | -$500.00 K(<-9900.0%) |
| Sept 2011 | - | $0.00(-100.0%) | $0.00(0.0%) |
| June 2011 | - | -$1.22 M(-269.1%) | $0.00(-100.0%) |
| Mar 2011 | - | $724.00 K(+44.8%) | $1.22 M(+144.8%) |
| Dec 2010 | $500.00 K(-94.5%) | $500.00 K(>+9900.0%) | $500.00 K(-91.4%) |
| Sept 2010 | - | $0.00(0.0%) | $5.82 M(-2.8%) |
| June 2010 | - | $0.00(0.0%) | $5.99 M(-33.5%) |
| Mar 2010 | - | $0.00(-100.0%) | $9.01 M(0.0%) |
| Dec 2009 | $9.01 M(+34.0%) | $5.82 M(+3322.4%) | $9.01 M(+182.2%) |
| Sept 2009 | - | $170.00 K(-94.4%) | $3.19 M(+5.6%) |
| June 2009 | - | $3.02 M(>+9900.0%) | $3.02 M(+6.2%) |
| Dec 2008 | $6.72 M(+136.2%) | - | - |
| June 2008 | - | $0.00(-100.0%) | $2.85 M(0.0%) |
| June 2008 | $2.85 M | - | - |
| Mar 2008 | - | $1.33 M(>+9900.0%) | $2.85 M(+88.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2007 | - | $7300.00(-99.5%) | $1.51 M(+0.5%) |
| Sept 2007 | - | $1.50 M(>+9900.0%) | $1.50 M(>+9900.0%) |
| June 2007 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2006 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2006 | - | $0.00(0.0%) | $39.20 K(-38.9%) |
| Dec 2005 | - | $0.00(0.0%) | $64.20 K(0.0%) |
| Sept 2005 | - | $0.00(-100.0%) | $64.20 K(0.0%) |
| June 2005 | $64.20 K(>+9900.0%) | $39.20 K(+56.8%) | $64.20 K(+156.8%) |
| Mar 2005 | - | $25.00 K(>+9900.0%) | $25.00 K(>+9900.0%) |
| Dec 2004 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2004 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2004 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2004 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2003 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2002 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2002 | - | $0.00(0.0%) | -$9200.00(-87.1%) |
| June 2002 | -$71.20 K(-95.8%) | $0.00(0.0%) | -$71.20 K(-96.2%) |
| Mar 2002 | - | $0.00(-100.0%) | -$1.88 M(-0.2%) |
| Dec 2001 | - | -$9200.00(-85.2%) | -$1.88 M(+0.5%) |
| Sept 2001 | - | -$62.00 K(-96.6%) | -$1.87 M(+9.3%) |
| June 2001 | -$1.71 M(-130.4%) | -$1.81 M(>+9900.0%) | -$1.71 M(-142.5%) |
| Mar 2001 | - | -$4100.00(<-9900.0%) | $4.03 M(-29.9%) |
| Dec 2000 | - | $0.00(-100.0%) | $5.75 M(0.0%) |
| Sept 2000 | - | $98.00 K(-97.5%) | $5.75 M(+1.7%) |
| June 2000 | $5.65 M(>+9900.0%) | $3.94 M(+129.9%) | $5.65 M(+229.9%) |
| Mar 2000 | - | $1.71 M(>+9900.0%) | $1.71 M(>+9900.0%) |
| Dec 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 1999 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Mar 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 1998 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 1998 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 1998 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 1998 | - | $0.00(0.0%) | $100.00 K(0.0%) |
| Dec 1997 | - | $0.00(0.0%) | $100.00 K(-97.8%) |
| Sept 1997 | - | $0.00(-100.0%) | $4.50 M(+2.3%) |
| June 1997 | $4.40 M(-2850.0%) | $100.00 K(>+9900.0%) | $4.40 M(+2.3%) |
| Mar 1997 | - | $0.00(-100.0%) | $4.30 M(0.0%) |
| Dec 1996 | - | $4.40 M(-4500.0%) | $4.30 M(-4400.0%) |
| Sept 1996 | - | -$100.00 K | -$100.00 K |
| June 1996 | -$160.00 K | - | - |
FAQ
- What is BioCardia annual cash flow from financing activities?
- What is the all time high annual CFF for BioCardia?
- What is BioCardia annual CFF year-on-year change?
- What is BioCardia quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for BioCardia?
- What is BioCardia quarterly CFF year-on-year change?
- What is BioCardia TTM cash flow from financing activities?
- What is the all time high TTM CFF for BioCardia?
- What is BioCardia TTM CFF year-on-year change?
What is BioCardia annual cash flow from financing activities?
The current annual CFF of BCDA is $3.73 M
What is the all time high annual CFF for BioCardia?
BioCardia all-time high annual cash flow from financing activities is $28.21 M
What is BioCardia annual CFF year-on-year change?
Over the past year, BCDA annual cash flow from financing activities has changed by -$1.40 M (-27.25%)
What is BioCardia quarterly cash flow from financing activities?
The current quarterly CFF of BCDA is $6.12 M
What is the all time high quarterly CFF for BioCardia?
BioCardia all-time high quarterly cash flow from financing activities is $17.43 M
What is BioCardia quarterly CFF year-on-year change?
Over the past year, BCDA quarterly cash flow from financing activities has changed by +$6.18 M (+10655.17%)
What is BioCardia TTM cash flow from financing activities?
The current TTM CFF of BCDA is $10.40 M
What is the all time high TTM CFF for BioCardia?
BioCardia all-time high TTM cash flow from financing activities is $30.22 M
What is BioCardia TTM CFF year-on-year change?
Over the past year, BCDA TTM cash flow from financing activities has changed by +$4.10 M (+65.09%)